Noncurrent long-term debt increased 20.7%
Noncurrent long-term debt changed +20.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Noncurrent long-term debt changed +20.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Capital expenditure changed +83.6% from the comparable as-filed period.
Cash / debt changed +518 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating cash flow changed -12.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed +16.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Debt / revenue changed -2297 basis points from the comparable as-filed period.
Operating cash-flow margin changed -380 basis points from the comparable as-filed period.
Operating cash flow / net income changed -75.4% from the comparable as-filed period.
Free-cash-flow margin changed -417 basis points from the comparable as-filed period.
Net debt changed +11.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -166 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed +37 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +15.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed -21 basis points from the comparable as-filed period.
Stock-based compensation changed +2.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
R&D / revenue changed -28 basis points from the comparable as-filed period.
Inventory / revenue changed +261 basis points from the comparable as-filed period.
Research & development changed +21.7% from the comparable as-filed period.
Debt changed +8.3% from the comparable as-filed period.
Capex / revenue changed -23 basis points from the comparable as-filed period.
SBC / revenue changed -38 basis points from the comparable as-filed period.
Selling, general & administrative changed +6.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 5 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.